HCPLive Network

Appropriate Use Criteria Established for Amyloid PET

 
TUESDAY, Jan. 29 (HealthDay News) -- Experts have agreed upon appropriate use criteria for positron emission tomography (PET) of brain amyloid β, according to a report published online Jan. 28 in Alzheimer's & Dementia.

Keith A. Johnson, M.D., from Massachusetts General Hospital in Boston, and colleagues, together with the Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging, convened the Amyloid Imaging Task Force to provide guidance to dementia care practitioners, patients, and caregivers. Peer-reviewed, published literature was reviewed to develop a consensus opinion about the use of amyloid PET in specific clinical scenarios.

The researchers developed and agreed upon a series of specific appropriate use criteria to define the patients and clinical circumstances in which amyloid PET could be used. Amyloid imaging is appropriate when the following criteria are met: there is evidence of a cognitive complaint with objectively confirmed impairment; when Alzheimer's disease is a possible diagnosis, but that diagnosis is uncertain after a comprehensive evaluation by an expert; and when knowledge of amyloid pathology is likely to increase diagnostic certainty and alter management.

"Because both dementia care and amyloid PET technology are in active development, these appropriate use criteria will require periodic reassessment," the authors write. "Future research directions are also outlined, including diagnostic utility and patient-centered outcomes."

Multiple Task Force members and reviewers disclosed financial ties to pharmaceutical and other health care companies.
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 

Further Reading
Treatment failure can be caused by a variety of factors, including misdiagnosis of the primary psychiatric complaint, the presence of one or more comorbid conditions, and nonadherence to medication plans.
When treating patients who have been diagnosed with cancer, you should consult with their oncologist to brainstorm interventions that can help your patient have the best possible quality of life.
Prolonged exposure therapy can help veterans with post-traumatic stress disorder overcome the fear, anxiety, and depression that can lead to avoidance behaviors and other responses that negatively impact quality of life.
App will help patients with diabetes log their hypoglycemic events and achieve better control of these events by becoming more aware of preceding signs and symptoms.
Provocative research raises the question of whether we should we look at Alzheimer’s disease as “type 3 diabetes.”
Presentation at CMHC 2014 provides updates on emerging classes of diabetes treatment, including preliminary data from current clinical trials.
In remarks delivered at the American Academy of Family Physicians 2014 Assembly, HHS Secretary Sylvia Mathews Burwell spoke about the ongoing response to the Ebola outbreak, improving health care delivery, the Affordable Care Act, and the Transforming Clinical Practice Initiative.
More Reading